Participatory Approach definition

Participatory Approach means and refers to the active association and involvement of the people or the community in policy-formulation, project- planning or implementation, or activity, scheme, programme, project or institutional arrangements of any kind;
Sample 1Sample 2
Participatory Approach means a method for the use of (i) standing advisory committees, (ii) ad hoc advisory groups or panels, (iii) consultation with groups or individuals registering interest in working with the agency, or (iv) any combination thereof in the formation and development of regulations for agency consideration. When an ad hoc advisory group is formed, the group shall include representatives of the regulated community and the general public. The decisions as to the membership of the group shall be at the discretion of the director.
Sample 1Sample 2
Participatory Approach means more than just consulting communities about their wishes. It requires serious dialogue in which these communities are allowed to have substantial leeway for negotiation. (GTZ/ UNDOC, The Role of Alternative Development in Drug
Sample 1

Examples of Participatory Approach in a sentence

  • Participatory approach has been adopted to identify the activities under the project.

  • Participatory approach will be used in the process to let the villagers decide by themselves what would suit best to their actual conditions.

  • Participatory approach to framing environmental and social governance under RDP III as well as for planning of environmental and social impact mitigation is essential for ensuring quality and realism of safeguard documents.

  • Participatory approach refers to the involvement of older persons in assessing the impact of policy actions on the quality of their lives.

  • Participatory approach is appropriate when it comes to the issues of school administration because school is an organization with people having different views, opinions; perception, knowledge and understanding capacity and exposure differ from one another.

  • While the recommendation could be implemented through a small pilot with the individual pledge and total amounts capped, it would also require longer term measures to be put in place to track the progress of pledges, to ensure that donors meet the terms of the pledged gifts.

  • Participatory approach to framing environmental and social governance under LEID Project as well as for planning of environmental and social impact mitigation is essential for ensuring quality and realism of safeguard documents.

  • Participatory approach was used to involve the citizens, local authorities and stakeholders (Private Sector, Civil society and other development partners in order to create a spirit of ownership.

  • Participatory approach was used to involve the population and stakeholders in order to create a spirit of ownership.

  • Participatory approach The development of the Government’s “Ecole de Demain” reform program involved an extensive one-year national consultation process.

Related to Participatory Approach

  • Regulatory Approval means any and all approvals (including MAA Approval, and Pricing and Reimbursement Approval, if applicable), licenses, registrations, permits, notifications and authorizations (or waivers) of any Regulatory Authority that are necessary for the manufacture, use, storage, import, transport, promotion, marketing, distribution, offer for sale, sale or other commercialization of a Product in any country or jurisdiction.

  • Regulatory Approval Application means any application submitted to an appropriate Regulatory Authority seeking any Regulatory Approval.

  • Development Milestone is defined in Section 5.3.

  • continuing candidate means any candidate not deemed to be elected, and not excluded,

  • NDA Approval means the Approval of an NDA by the FDA for a Product in the U.S.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Regulatory Exclusivity Period means, with respect to each Licensed Product in any country in the Territory, a period of exclusivity (other than Patent exclusivity) granted or afforded by Applicable Law or by a Regulatory Authority in such country that confers exclusive marketing rights with respect to such Licensed Product in such country or prevents another Person from using or otherwise relying on any data supporting the approval of the Drug Approval Application for such Licensed Product to support an application for regulatory approval of another product for any indication without the prior written consent of the Drug Approval Application holder.

  • Commercial cannabis activity means the production, cultivation,

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • FDA Approval means the approval, license, clearance or authorization of the FDA necessary for the marketing and sale of a product for human use in the United States.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Development Milestone Event has the meaning set forth in Section 7.2.1.

  • Specific contract participation goals means the goals as stipulated in the Preferential Procurement Regulations, 2001. In addition to above-mentioned goals, the Regulations [12. (1)] also make provision for organs of State to give particular consideration to procuring locally manufactured products.

  • Marketing Approval Application or “MAA” means a New Drug Application (or its equivalent), as defined in the U.S. Food, Drug and Cosmetic Act and the regulations promulgated thereunder, or any corresponding or similar application, registration or certification in any country.

  • Stage means level of progress of the works identified as such and more particularly described in the Employer’s Requirements for which a Key Date for the achievement thereof is stipulated in the Contract.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Regulatory Exclusivity means any exclusive marketing rights or data exclusivity rights conferred by any Regulatory Authority with respect to a pharmaceutical product other than Patents, including orphan drug exclusivity, new chemical entity exclusivity, data exclusivity, or pediatric exclusivity.

  • Development Activity means any activity defined as Development which will necessitate a Floodplain Development Permit. This includes buildings, structures, and non-structural items, including (but not limited to) fill, bulkheads, piers, pools, docks, landings, ramps, and erosion control/stabilization measures.

  • Marketing Approval means all approvals, licenses, registrations or authorizations of the Regulatory Authority in a country, necessary for the manufacture, use, storage, import, marketing and sale of a Product in such country.

  • Launch means the intentional ignition of the first-stage motor(s) of the Launch Vehicle intended to place or try to place a Launch Vehicle (which may or may not include any Transfer Vehicle, Payload or crew) from Earth:

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Clinical Trial means any human clinical trial of a Product.

  • Competitive Product means a product or service, made or provided by a Competitor, which is the same as or is directly competitive with one with respect to which the Employee acquired confidential information relating to the Company, or its business, products or services by reason of the Employee's work with the Company.

  • Key Regulatory Approvals means those sanctions, rulings, consents, orders, exemptions, permits and other approvals (including the lapse, without objection, of a prescribed time under a statute or regulation that states that a transaction may be implemented if a prescribed time lapses following the giving of notice without an objection being made) of Governmental Entities as set out in Schedule C hereto;